Peanut allergy drug could be ready by 2018

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

BAGNEAUX, France -- People who suffer from peanut allergies may soon find some relief.

A small pharmaceutical company in France is working on a drug that would help people tolerate peanuts.

The drug is called "Viaskin Peanut," and is administered in the form of a patch, similar to nicotine patches.

The FDA recently gave it approval for fast-track testing. If all goes well, it could be available in the U.S. by early 2018.

Peanuts are among eight food groups that account for 90 percent of serious allergic reactions in children in the U.S., according to the CDC. Others are: milk, eggs, fish, crustacean shellfish, wheat, soy and tree nuts.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s